UDEMY INC (UDMY)

US9026851066 - Common Stock

9.94  +0.05 (+0.51%)

After market: 9.94 0 (0%)

Fundamental Rating

4

UDMY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 66 industry peers in the Diversified Consumer Services industry. UDMY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. UDMY is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year UDMY was profitable.
In the past year UDMY had a positive cash flow from operations.
UDMY had negative earnings in each of the past 5 years.
UDMY had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -11.45%, UDMY is doing worse than 62.50% of the companies in the same industry.
UDMY has a Return On Equity (-27.35%) which is in line with its industry peers.
Industry RankSector Rank
ROA -11.45%
ROE -27.35%
ROIC N/A
ROA(3y)-15.38%
ROA(5y)-26.62%
ROE(3y)-31.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UDMY has a better Gross Margin (58.75%) than 68.75% of its industry peers.
UDMY's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for UDMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.88%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

UDMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
UDMY has more shares outstanding than it did 1 year ago.
There is no outstanding debt for UDMY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

UDMY has an Altman-Z score of 1.70. This is a bad value and indicates that UDMY is not financially healthy and even has some risk of bankruptcy.
UDMY has a Altman-Z score of 1.70. This is in the better half of the industry: UDMY outperforms 62.50% of its industry peers.
UDMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.7
ROIC/WACCN/A
WACC9.02%

2.3 Liquidity

A Current Ratio of 1.48 indicates that UDMY should not have too much problems paying its short term obligations.
UDMY has a Current ratio of 1.48. This is comparable to the rest of the industry: UDMY outperforms 57.81% of its industry peers.
A Quick Ratio of 1.48 indicates that UDMY should not have too much problems paying its short term obligations.
UDMY has a better Quick ratio (1.48) than 60.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.15% over the past year.
UDMY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.71%.
UDMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.25% yearly.
EPS 1Y (TTM)119.15%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q150%
Revenue 1Y (TTM)14.71%
Revenue growth 3Y19.25%
Revenue growth 5YN/A
Revenue growth Q2Q11.57%

3.2 Future

UDMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42041300.00% yearly.
Based on estimates for the next years, UDMY will show a quite strong growth in Revenue. The Revenue will grow by 8.75% on average per year.
EPS Next Y243721841466364350%
EPS Next 2Y17893851825.18%
EPS Next 3Y42041300%
EPS Next 5YN/A
Revenue Next Year10.63%
Revenue Next 2Y12.32%
Revenue Next 3Y11.66%
Revenue Next 5Y8.75%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

UDMY is valuated quite expensively with a Price/Earnings ratio of 110.44.
UDMY's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.60. UDMY is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 44.74, the valuation of UDMY can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as UDMY.
UDMY is valuated expensively when we compare the Price/Forward Earnings ratio to 20.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 110.44
Fwd PE 44.74

4.2 Price Multiples

UDMY's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 59.28
EV/EBITDA N/A

4.3 Compensation for Growth

UDMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as UDMY's earnings are expected to grow with 42041300.00% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y17893851825.18%
EPS Next 3Y42041300%

0

5. Dividend

5.1 Amount

UDMY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UDEMY INC

NASDAQ:UDMY (5/17/2024, 7:00:01 PM)

After market: 9.94 0 (0%)

9.94

+0.05 (+0.51%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.52B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 110.44
Fwd PE 44.74
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.45%
ROE -27.35%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 58.75%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)119.15%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y243721841466364350%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.71%
Revenue growth 3Y19.25%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y